CompletedPhase 3

Major Depressive Disorder With Mixed Features - Extension

NCT01423253

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Birmingham Psychiatry Pharmaceutical Studies, Inc

Birmingham, Alabama, United States

+16 additional locations

Save this trial

Birmingham Psychiatry Pharmaceutical Studies, IncBirmingham, Alabama, United States
Synergy Clinical Research CenterEscondido, California, United States
Collaborative Neuro Science Network, Inc.Garden Grove, California, United States
Stanford -VA Palo Alto Health Care SystemPalo Alto, California, United States
Artemis Institute for Clinical ResearchSan Diego, California, United States
Florida Clinical Research Center, LLCSarasota, Florida, United States
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress DisordersBoston, Massachusetts, United States
St. Charles Psychiatric Associates/Midwest Research GroupSaint Charles, Missouri, United States
Village Clinical Research Inc.New York, New York, United States
Finger Lakes Clinical ResearchRochester, New York, United States
Behavioral Medical Research of Staten IslandStaten Island, New York, United States
Psychiatry and Behavioral Sciences, DukeDurham, North Carolina, United States
Midwest Clinical Research CenterDayton, Ohio, United States
CRI Worldwide - KirkbridePhiladelphia, Pennsylvania, United States
FutureSearch Trials of Dallas, LPDallas, Texas, United States
Dept. of Psychiatry, UT Southwestern Medical CenterDallas, Texas, United States
Grayline Clinical Drug TrialsWichita Falls, Texas, United States